180 related articles for article (PubMed ID: 33247612)
1. The clinically used serine protease inhibitor nafamostat reduces influenza virus replication and cytokine production in human airway epithelial cells and viral replication in mice.
Yamaya M; Shimotai Y; Ohkawara A; Bazarragchaa E; Okamatsu M; Sakoda Y; Kida H; Nishimura H
J Med Virol; 2021 Jun; 93(6):3484-3495. PubMed ID: 33247612
[TBL] [Abstract][Full Text] [Related]
2. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Shimotai Y; Hatachi Y; Lusamba Kalonji N; Tando Y; Kitajima Y; Matsuo K; Kubo H; Nagatomi R; Hongo S; Homma M; Nishimura H
Pulm Pharmacol Ther; 2015 Aug; 33():66-74. PubMed ID: 26166259
[TBL] [Abstract][Full Text] [Related]
3. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
4. Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness.
Yates AG; Weglinski CM; Ying Y; Dunstan IK; Strekalova T; Anthony DC
J Neuroinflammation; 2022 Jan; 19(1):8. PubMed ID: 34991643
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.
Bahgat MM; Błazejewska P; Schughart K
Virol J; 2011 Jan; 8():27. PubMed ID: 21251300
[TBL] [Abstract][Full Text] [Related]
6. The effects of neuraminidase inhibitors on the release of oseltamivir-sensitive and oseltamivir-resistant influenza viruses from primary cultures of human tracheal epithelium.
Yamaya M; Nadine L; Kubo H; Saito K; Saito R; Nishimura H
J Med Virol; 2015 Jan; 87(1):25-34. PubMed ID: 24838828
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.
Sato K; Hayashi H; Shimotai Y; Yamaya M; Hongo S; Kawakami K; Matsuzaki Y; Nishimura H
J Virol; 2021 Oct; 95(21):e0129621. PubMed ID: 34406864
[TBL] [Abstract][Full Text] [Related]
8. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.
Yamaya M; Nishimura H; Deng X; Sugawara M; Watanabe O; Nomura K; Shimotai Y; Momma H; Ichinose M; Kawase T
Respir Investig; 2020 May; 58(3):155-168. PubMed ID: 32094077
[TBL] [Abstract][Full Text] [Related]
10. Magnitude of influenza virus replication and cell damage is associated with interleukin-6 production in primary cultures of human tracheal epithelium.
Yamaya M; Nadine LK; Ota C; Kubo H; Makiguchi T; Nagatomi R; Nishimura H
Respir Physiol Neurobiol; 2014 Oct; 202():16-23. PubMed ID: 25064661
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells.
Yamaya M; Shinya K; Hatachi Y; Kubo H; Asada M; Yasuda H; Nishimura H; Nagatomi R
J Pharmacol Exp Ther; 2010 Apr; 333(1):81-90. PubMed ID: 20040578
[TBL] [Abstract][Full Text] [Related]
12. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
[TBL] [Abstract][Full Text] [Related]
13. Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.
Bestle D; Limburg H; Kruhl D; Harbig A; Stein DA; Moulton H; Matrosovich M; Abdelwhab EM; Stech J; Böttcher-Friebertshäuser E
J Virol; 2021 Sep; 95(20):e0090621. PubMed ID: 34319155
[TBL] [Abstract][Full Text] [Related]
14. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
[TBL] [Abstract][Full Text] [Related]
15. The RNA binding domain of influenza A virus NS1 protein affects secretion of tumor necrosis factor alpha, interleukin-6, and interferon in primary murine tracheal epithelial cells.
Newby CM; Sabin L; Pekosz A
J Virol; 2007 Sep; 81(17):9469-80. PubMed ID: 17596305
[TBL] [Abstract][Full Text] [Related]
16. TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice.
Tarnow C; Engels G; Arendt A; Schwalm F; Sediri H; Preuss A; Nelson PS; Garten W; Klenk HD; Gabriel G; Böttcher-Friebertshäuser E
J Virol; 2014 May; 88(9):4744-51. PubMed ID: 24522916
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells.
Yamaya M; Nishimura H; Shinya K; Hatachi Y; Sasaki T; Yasuda H; Yoshida M; Asada M; Fujino N; Suzuki T; Deng X; Kubo H; Nagatomi R
Am J Physiol Lung Cell Mol Physiol; 2010 Aug; 299(2):L160-8. PubMed ID: 20543005
[TBL] [Abstract][Full Text] [Related]
18. Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma.
Ishizaki M; Tanaka H; Kajiwara D; Toyohara T; Wakahara K; Inagaki N; Nagai H
J Pharmacol Sci; 2008 Nov; 108(3):355-63. PubMed ID: 19008643
[TBL] [Abstract][Full Text] [Related]
19. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
20. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.
Fage C; Hénaut M; Carbonneau J; Piret J; Boivin G
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
